Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

SBC Medical Group Holdings (SBC) Interest Expenses (2023 - 2025)

SBC Medical Group Holdings filings provide 3 years of Interest Expenses readings, the most recent being $65097.0 for Q4 2025.

  • On a quarterly basis, Interest Expenses rose 424.89% to $65097.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 million, a 6326.05% increase, with the full-year FY2025 number at $160583.0, up 467.43% from a year prior.
  • Interest Expenses hit $65097.0 in Q4 2025 for SBC Medical Group Holdings, up from $6564.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.7 million in Q1 2025 to a low of -$535947.0 in Q4 2023.
  • Median Interest Expenses over the past 3 years was $6994.0 (2024), compared with a mean of $131490.2.
  • The widest YoY moves for Interest Expenses: up 56324.83% in 2025, down 20.09% in 2025.
  • SBC Medical Group Holdings' Interest Expenses stood at -$535947.0 in 2023, then surged by 102.31% to $12402.0 in 2024, then surged by 424.89% to $65097.0 in 2025.
  • The last three reported values for Interest Expenses were $65097.0 (Q4 2025), $6564.0 (Q3 2025), and $49651.0 (Q2 2025) per Business Quant data.